Case Discussion on Stage IIIA N2 NSCLC, with Drs. Blumenschein & Curran

Several weeks ago I had the opportunity to discuss a series of cases of locally advanced NSCLC with a couple of expert colleagues: Dr. George Blumenschein, medical oncologist in the Division of Thoracic & Head/Neck Oncology at MD Anderson Cancer Center in Houston, TX; and Dr. Walter Curran, radiation oncologist who heads the Division of [...]

Podcast: Play in new window | Download

Podcast of Q&A Portion from Molecular Markers Webinar with Dr. Pennell

   Here’s the podcast of the Q&A portion of the excellent webinar with Dr. Pennell on Molecular Markers in Management of NSCLC. 
dr-pennell-molecular-markers-qa-audio-podcast
dr-pennell-molecular-markers-qa-transcript
dr-pennell-molecular-markers-qa-figures

Podcast: Play in new window | Download

Dr. Alan Sandler Provides General Intro to Treatment of Advanced Non-Small Cell Lung Cancer

Dr. Alan Sandler is an international leader in the lung cancer world, also identified as among the most down to earth and funniest people in the field (and though that might not sound like much, he travels with an audio clip of a rim shot to play after his jokes).  His talks are light-hearted, but [...]

Podcast: Play in new window | Download

Dr. Gerard Silvestri, Pulmonologist, on Lung Cancer Workup and Staging

This is the first of the presentations by guest speakers at our NSCLC Patient Education Forum back in September.   Dr. Gerard Silvestri is a pulmonologist, a lung disease specialist (not only cancer), and he is also one of the most important leaders in lung cancer within the field of pulmonology, as both a writer [...]

Podcast: Play in new window | Download

BAC No More?

The most expert lung cancer pathologists in the world are planning a revision of the classification of lung adenocarcinomas that is expected to be approved and implemented next year, and it’s going to make some big changes.  Specifically, it’s planning to eliminate the diagnosis of bronchioloalveolar carcinoma (BAC), reflecting our evolving understanding of this disease.
BAC [...]

Clinical Factors on the FLEX Trial: Do Certain Patient Groups Benefit More or Less with Erbitux?

In the last post that presented the highlights of the FLEX trial that tested the benefit of adding Ebritux (cetuximab) to standard chemo.  The trial was technically positive, statistically significant, but the results in the overall population of the trial were so marginally superior with Erbitux that a very logical follow-up question is whether we [...]

Interview with Dr. Suresh Ramalingam on First Line and Maintenance Therapy for Advanced NSCLC

   The ASCO meeting I’m at right now is so busy that there really isn’t time to write a new post (though I’m still “tweeting from the meeting”).  Though the talk show hows just air re-runs of old shows when they’re on vacation, I’m trying to continue to add new content to the website during [...]

Podcast: Play in new window | Download

Interview with Dr. Ramalingam on First Line Advanced NSCLC and Maintenance Therapy

    The ASCO meeting I’m at right now is so insanely busy during the days and nights that it’s next to impossible to carve out the time to write posts during the meeting.  While the talk show hosts just show re-runs while they’re on vacation, we’re at least going to put up some new content, [...]

Podcast: Play in new window | Download

Video Presentation on Timing of Chemo after First Line for Advanced NSCLC

   With special thanks to Harvey and Bernice Janssen for providing support to make it possible, I’m pleased to post a new video presentation on the topic of Timing the Transition to Maintenance/Second Line Chemotherapy for Advanced NSCLC.  We can expect new information to emerge in the coming months and years, but here is the [...]

Podcast: Play in new window | Download

Lung Cancer and the Enzyme Connection

Erlotinib (Tarceva) was approved for treatment of progressive non-small cell lung cancer (NSCLC) after the BR21 study that showed that tarceva not only improved survival but also improved lung cancer symptoms and quality of life. This study and others have also taught us that the benefit of tarceva is much better in [...]